JOHNSON & JOHNSON

10% owner at Kenvue Inc. · on record since May 3, 2023
10% owner at UNIVERSAL BIOSENSORS INC · on record since Jun 29, 2007
10% owner at IMMUNICON CORP · on record since Apr 14, 2004
10% owner at Contineum Therapeutics, Inc. · on record since Apr 10, 2024
10% owner at eXegenics Inc · on record since Apr 6, 2007
10% owner at BARRIER THERAPEUTICS INC · on record since Apr 28, 2004
10% owner at CRITICAL THERAPEUTICS INC · on record since May 26, 2004
10% owner at TENGION INC · on record since Apr 14, 2010
10% owner at Neurogene Inc. · on record since Mar 12, 2014
10% owner at GENOCEA BIOSCIENCES, INC. · on record since Feb 11, 2014
10% owner at PROTEIN POLYMER TECHNOLOGIES INC · on record since Feb 17, 2004
10% owner at Aldeyra Therapeutics, Inc. · on record since May 5, 2014
10% owner at Minerva Neurosciences, Inc. · on record since Jul 17, 2014
10% owner at NEVRO CORP · on record since Nov 12, 2014
10% owner at ACHILLION PHARMACEUTICALS INC · on record since Jul 6, 2015
10% owner at Protagonist Therapeutics, Inc · on record since Aug 18, 2016
10% owner at Inspire Medical Systems, Inc. · on record since May 7, 2018
10% owner at POWDER RIVER BASIN GAS CORP · on record since Jul 20, 2018
10% owner at · on record since Mar 11, 2005
10% owner at · on record since Jun 25, 2020
10% owner at · on record since Jun 29, 2021
10% owner at · on record since Nov 14, 2022
10% owner at · on record since Dec 21, 2005

Insider trading activity of JOHNSON & JOHNSON

Transactions on record: 111; since Feb 17, 2004

Open-market buys: 6; $23M

Open-market sells: 50; $97.4M

Companies traded: 13; last filing Nov 25, 2025

Figures computed from official regulatory filings — .

Companies where JOHNSON & JOHNSON has traded

3 tx · $37.1K · Nov 25, 2025
1 tx · Aug 25, 2023
6 tx · $12.3M · Jul 2, 2020
4 tx · May 7, 2018
3 tx · $6M · Feb 12, 2016
22 tx · $37.1M · Aug 12, 2015
5 tx · $49.2M · Jun 8, 2015
3 tx · Feb 11, 2014
36 tx · $1.3M · Jan 24, 2012
9 tx · $13.5M · Feb 15, 2005
12 tx · $32K · Jun 14, 2004
4 tx · $999.6K · Jun 2, 2004
3 tx · $1M · Feb 17, 2004

Track record of JOHNSON & JOHNSON

Statistical track record

Free

Open-market buys: 10

Last buy: Jun 30, 2020

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of JOHNSON & JOHNSON

Co-insiders of JOHNSON & JOHNSON

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
CVRx, Inc.	Nov 25, 2025	Sell	-500	10.00 USD	$5K	SEC
CVRx, Inc.	Nov 25, 2025	Sell	-2,200	10.06 USD	$22.1K	SEC
CVRx, Inc.	Nov 14, 2025	Sell	-1,000	10.00 USD	$10K	SEC
Kenvue Inc.	Aug 25, 2023	Other	-1,533,830,450	—	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	-475,802	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	89,118	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	-5,059,460	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	Buy	725,000	17.00 USD	$12.3M	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	-10,666,667	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	Other	2,945,516	—	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	Other	37,388	—	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	Other	197,863	—	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	OtherD (derivative)	-248,631	0.00 USD	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	OtherD (derivative)	-1,145,038	0.00 USD	—	SEC
Minerva Neurosciences, Inc.	Feb 12, 2016	Buy	607,903	4.93 USD	$3M	SEC
Neurogene Inc.	Aug 12, 2015	Sell	-1,283,366	20.74 USD	$26.6M	SEC
Neurogene Inc.	Aug 12, 2015	Sell	-231,455	31.66 USD	$7.3M	SEC
NEVRO CORP	Jun 8, 2015	Sell	-1,010,265	47.94 USD	$48.4M	SEC
Minerva Neurosciences, Inc.	Mar 17, 2015	Buy	607,903	4.81 USD	$2.9M	SEC
Minerva Neurosciences, Inc.	Mar 17, 2015	BuyD (derivative)	607,903	0.13 USD	$79K	SEC
Neurogene Inc.	Feb 3, 2015	OtherD (derivative)	-255,681	0.00 USD	—	SEC
Neurogene Inc.	Feb 3, 2015	Buy	272,727	11.00 USD	$3M	SEC
Neurogene Inc.	Feb 3, 2015	OtherD (derivative)	-379,543	0.00 USD	—	SEC
Neurogene Inc.	Feb 3, 2015	OtherD (derivative)	-293,884	0.00 USD	—	SEC
Neurogene Inc.	Feb 3, 2015	Other	1,392,094	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CVRx, Inc.	Nov 25, 2025	Sell	-500	10.00 USD	$5K	SEC
CVRx, Inc.	Nov 25, 2025	Sell	-2,200	10.06 USD	$22.1K	SEC
CVRx, Inc.	Nov 14, 2025	Sell	-1,000	10.00 USD	$10K	SEC
Kenvue Inc.	Aug 25, 2023	Other	-1,533,830,450	—	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	-475,802	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	89,118	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	-5,059,460	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	Buy	725,000	17.00 USD	$12.3M	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	OtherD (derivative)	-10,666,667	0.00 USD	—	SEC
Fusion Pharmaceuticals Inc.	Jul 2, 2020	Other	2,945,516	—	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	Other	37,388	—	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	Other	197,863	—	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	OtherD (derivative)	-248,631	0.00 USD	—	SEC
Inspire Medical Systems, Inc.	May 7, 2018	OtherD (derivative)	-1,145,038	0.00 USD	—	SEC
Minerva Neurosciences, Inc.	Feb 12, 2016	Buy	607,903	4.93 USD	$3M	SEC
Neurogene Inc.	Aug 12, 2015	Sell	-1,283,366	20.74 USD	$26.6M	SEC
Neurogene Inc.	Aug 12, 2015	Sell	-231,455	31.66 USD	$7.3M	SEC
NEVRO CORP	Jun 8, 2015	Sell	-1,010,265	47.94 USD	$48.4M	SEC
Minerva Neurosciences, Inc.	Mar 17, 2015	Buy	607,903	4.81 USD	$2.9M	SEC
Minerva Neurosciences, Inc.	Mar 17, 2015	BuyD (derivative)	607,903	0.13 USD	$79K	SEC
Neurogene Inc.	Feb 3, 2015	OtherD (derivative)	-255,681	0.00 USD	—	SEC
Neurogene Inc.	Feb 3, 2015	Buy	272,727	11.00 USD	$3M	SEC
Neurogene Inc.	Feb 3, 2015	OtherD (derivative)	-379,543	0.00 USD	—	SEC
Neurogene Inc.	Feb 3, 2015	OtherD (derivative)	-293,884	0.00 USD	—	SEC
Neurogene Inc.	Feb 3, 2015	Other	1,392,094	—	—	SEC